This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Manufacturing Services

Contained Operations Overview

PCI is able to demonstrate a long and successful track record in the development and manufacture of products

Our facilities and capability for handling potent products enables the safe development, clinical and commercial supply of products with an OEL as low as 0.01μg/m3 (eight hour time weighted average).

Key attributes of our contained manufacturing service include:

  • Capability to process multiple compounds
  • Development scale to commercial scale batch sizes
  • Segregated people and material flows
  • Secure access and client viewing gallery
  • Automated cleaning procedures
  • Contained engineering solutions eliminating the need for PPE
  • HVAC system with single pass air
  • Temperature and humidity controlled processing areas
  • Small and large-scale packaging options
  • Meeting global regulatory standards including the MHRA, FDA, ANVISA, Turkish Ministry of Health and Japan
  • Purpose-built high performance bespoke effluent treatment facility
  • Design-for-manufacture delivering true speed-to-market

Our dedicated team of specialists will be happy to discuss any of your Contained Operations. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity... View Article

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued... View Article

x